Sei Investments CO Pacira Bio Sciences, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Sei Investments CO holds 22,158 shares of PCRX stock, worth $362,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,158

Previous 48,683 54.49%

Holding current value

$362,726

Previous $1.39 Million 76.08%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$11.7 - $28.46 $310,342 - $754,901	-26,525 Reduced 54.49%	22,158 $333,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $506,430 - $625,788	19,860 Added 68.9%	48,683 $1.39 Million
Q1 2024 May 07, 2024	BUY	$27.7 - $35.48 $15,927 - $20,401	575 Added 2.04%	28,823 $842,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $487,420 - $635,386	-18,519 Reduced 39.6%	28,248 $953,000
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $72,895 - $95,253	-2,376 Reduced 4.83%	46,767 $1.43 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $24,128 - $31,730	668 Added 1.38%	49,143 $1.97 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $388,165 - $473,926	10,925 Added 29.09%	48,475 $1.98 Million
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $2.01 Million - $3.02 Million	-52,604 Reduced 58.35%	37,550 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $84,648 - $97,286	-1,652 Reduced 1.8%	90,154 $4.8 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.95 Million - $3.1 Million	37,958 Added 70.49%	91,806 $5.39 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $332,506 - $423,678	5,539 Added 11.47%	53,848 $4.11 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $75,696 - $98,167	1,578 Added 3.38%	48,309 $2.93 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $158,182 - $177,463	2,895 Added 6.6%	46,731 $2.65 Million
Q2 2021 Aug 06, 2021	BUY	$59.18 - $69.99 $366,679 - $433,658	6,196 Added 16.46%	43,836 $2.68 Million
Q1 2021 May 12, 2021	BUY	$59.31 - $78.82 $119,153 - $158,349	2,009 Added 5.64%	37,640 $2.57 Million
Q4 2020 Feb 08, 2021	SELL	$50.47 - $66.26 $1.34 Million - $1.76 Million	-26,539 Reduced 42.69%	35,631 $2.16 Million
Q3 2020 Dec 04, 2020	SELL	$51.97 - $63.0 $382,551 - $463,743	-7,361 Reduced 10.59%	62,170 $3.76 Million
Q3 2020 Nov 06, 2020	BUY	$51.97 - $63.0 $1,974 - $2,394	38 Added 0.05%	69,531 $4.2 Million
Q2 2020 Aug 17, 2020	BUY	$30.8 - $52.47 $470,685 - $801,846	15,282 Added 28.19%	69,493 $3.68 Million
Q2 2020 Aug 11, 2020	SELL	$30.8 - $52.47 $176,699 - $301,020	-5,737 Reduced 9.57%	54,211 $2.69 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $362,895 - $647,844	12,778 Added 27.09%	59,948 $2.03 Million
Q4 2019 Feb 06, 2020	BUY	$36.31 - $46.83 $828,812 - $1.07 Million	22,826 Added 93.76%	47,170 $2.2 Million
Q3 2019 Nov 12, 2019	BUY	$35.66 - $44.99 $65,864 - $83,096	1,847 Added 8.21%	24,344 $927,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $368,918 - $483,921	10,088 Added 81.3%	22,497 $979,000
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $589,683 - $681,846	-16,169 Reduced 56.58%	12,409 $471,000
Q4 2018 Feb 13, 2019	BUY	$41.31 - $52.16 $605,687 - $764,769	14,662 Added 105.36%	28,578 $1.32 Million
Q3 2018 Nov 08, 2018	BUY	$32.85 - $52.0 $358,820 - $567,996	10,923 Added 364.95%	13,916 $685,000
Q2 2018 Aug 03, 2018	BUY	$27.5 - $39.8 $32,230 - $46,645	1,172 Added 64.36%	2,993 $96,000
Q1 2018 May 11, 2018	SELL	$29.98 - $46.35 $2,788 - $4,310	-93 Reduced 4.86%	1,821 $57,000
Q4 2017 Feb 08, 2018	SELL	$31.85 - $46.95 $752,456 - $1.11 Million	-23,625 Reduced 92.51%	1,914 $88,000
Q3 2017 Nov 06, 2017	BUY	$35.7 - $39.5 $911,742 - $1.01 Million	25,539	25,539 $959,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $750M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Pacira Bio Sciences, Inc. Transaction History